Vimarsana
Biggest News Aggregation in the World

Acute Suicidality News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acute Suicidality. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acute Suicidality Today - Breaking & Trending Today

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights - Vimarsana News

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights

/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announces...

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights -March 28, 2024 at 08:04 am EDT - Vimarsana News

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights -March 28, 2024 at 08:04 am EDT

Four potential near-term milestones, including data from two clinical trials, an NDA filing and a share dividend RADNOR, Pa., March 28, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a...

NRx Pharma Gains Rights To Data From Columbia University Supporting Use Of IV Ketamine - Vimarsana News

NRx Pharma Gains Rights To Data From Columbia University Supporting Use Of IV Ketamine

NRx Pharmaceuticals, Inc. (NRXP) has signed a License Data and Technical Information Agreement with Columbia University for rights to data from a randomized, active-controlled trial of 80 patients hospitalized for Acute Suicidality in Depression.

NRx Pharma Gains Rights To Data From Columbia University Supporting Use Of IV Ketamine - Vimarsana News

NRx Pharma Gains Rights To Data From Columbia University Supporting Use Of IV Ketamine

(RTTNews) - NRx Pharmaceuticals, Inc. (NRXP) has signed a License Data and Technical Information Agreement with Columbia University for rights to ...

NRX Pharmaceuticals Announces Data Sharing Agreement Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of SuicidalBipolar Depression - Vimarsana News

NRX Pharmaceuticals Announces Data Sharing Agreement Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of SuicidalBipolar Depression

RADNOR - NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that it has signed a data sharing agreement with the study leadership of a randomized,...